|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Cost-effectiveness of gatifloxacin vs ceftriaxone with a macrolide for the treatment of community-acquired pneumonia显示文摘 | Dresser LD Niederman MS Paladino JA | 2001 | Chest2001，119，5： | 1 |
| 2 | Cost-effectiveness of gatifloxacin vs ceftriaxone with a macrolide for the treatment of community-acquired pneumonia显示文摘 | Dresser LD Niedeman MS Paladino JA | 2001 | Chest2001，119，5： | 1 |
| 3 | Effects of NorA inhibitors on in vitro antibacterial activities and pastantibiotic effects of levofloxacin, ciprofloxacin, and norfloxacin in genetically related strains of Staphylococcus aureus 显示文摘 | Aeschlimann JR Dresser LD kaatz G W | 1999 | Antimicrob Agents Chemother1999，43，： | 1 |
| 4 | Cost-effectiveness of gatifloxacin vs ceftraxone with a macrolide for the treatment of community-acquired pneumonia显示文摘 | Dresser LD Niederman MS Paladino JA | 2001 | Chest2001，119，： | 1 |
| 5 | Effects of NorA inhibitors on in vitro antibacterial activities and postantibiotic effects of levofloxacin,ciprofloxacin,and norfloxacin in genetically related strains of Staphylococcus aureus显示文摘 | Aeschlimann JR Dresser LD Kaatz GW | 1999 | Antimicrob Agents Chemother1999，43，： | 1 |
| 6 | Effects of Nora in-hibitors on in vitro antibacterial activities and postantibiotic effects of levofloxacin, ciprofloxacin, and norfloxacin in genetically related strains of staphylococcus aurens 显示文摘 | Aeschlimann JR Dresser LD Kaatz GW | 1999 | Antimicrob Agents Chemother1999，43，2： | 1 |
| 7 | Cost-effectiveness of gatifloxacin vs ceftraxone with a macrolide for the treatment of community-acquired pneumonia显示文摘 | Dresser LD Niederman MS Paladino JA | 2001 | Chest2001，119，： | 1 |
| 8 | A nation- al survey of critical care physicians' knowledge, attitudes, and perceptions of antimicrobial stewardship programs显示文摘 | STEINBERG M DRESSER LD DANEMAN N | 2014 | J Intensive Care Med2014，，： | 1 |
| 9 | Cost-effectiveness of gatifloxacin vs ceftriaxone with a macrolide for the treatment of community-acquired pneumonia显示文摘 | Dresser LD Niederman MS Paladino JA | 2001 | Chest2001，119，5： | 1 |
| 10 | Cost-effectiveness of gatifloxacin vs ceftriaxone with a macrolide for the treatment of community-acquired pneumonia显示文摘 | Niedeman MS Paladino JP | 2001 | Chest2001，119，5： | 1 |
| 11 | Effects of NorA inhibitors on in vitro antibacterial activities and postantibiotic effects of levofloxacin,ciprofloxacin,and norfloxacin in genetically related strains of Staphylococcus aureus显示文摘 | Aeschlimann JR Dresser LD Kaatz GW | 1999 | Antimicrob Agents Chemother1999，43，2： | 1 |
| 12 | Cost-effectiveness of gatifloxacin vs ceftriaxone with a macrolide for the treatment of community-acquired pneumonia显示文摘 | Dresser LD Niederman MS Paladino JA | 2001 | Chest2001，119，5： | 1 |
| 13 | Cost-effectiveness of gatifloxacin vs ceftriaxone with a macrolide for the treatment of community-acquired pneumonia 显示文摘 | Dresser LD Niederman MS Paladino JA | 2001 | Chest2001，119，： | 1 |
| 14 | Cost - effective- ness of gatifloxacin vs ceftriaxone with a macrolide for the treatment of community- acquired pneumonia显示文摘 | Dresser LD Niedeman MS Paladino JA | 2001 | Chest2001，119，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员